| Source Date | Board Meeting Date | Details |
|
29-Jan-2026
|
04-Feb-2026
|
Quarterly Results
|
|
27-Nov-2025
|
29-Nov-2025
|
Fund raising
|
|
24-Nov-2025
|
26-Nov-2025
|
Inter alia, to consider, and if deemed appropriate, approve the following matters: 1. Amendments/modifications to the Articles of Association of the Company in such manner as may be deemed fit, subject to the approval of the shareholders of the Company by way of a special resolution. 2. Proposals for fund raising of up to such amount as decided by the Board of Directors by way of issue of non-convertible debentures, optionally convertible debentures and/or any other securities as decided by the Board of Directors, either in a single tranche or in multiple tranches, through preferential issue and/or any other method as decided by the Board of Directors, subject to compliance with the provisions of the Companies Act, 2013 and the rules prescribed thereunder, applicable regulations prescribed by the Securities and Exchange Board of India and any other applicable laws, and receipt of requisite statutory/regulatory approvals (including the approval of the shareholders of the Company, if and to the extent required) and third-party consents (if and to the extent required). 3. Any other matter(s) as the Board of Directors may propose, discuss and put to vote with the permission of the Chairperson.
|
|
10-Nov-2025
|
12-Nov-2025
|
Quarterly Results
|
|
16-Oct-2025
|
21-Oct-2025
|
Raising Funds
|
|
08-Aug-2025
|
14-Aug-2025
|
Quarterly Results
|
|
07-May-2025
|
12-May-2025
|
Audited Results
|
|
10-Mar-2025
|
13-Mar-2025
|
Inter alia, to consider and approve the proposal of availing Corporate term loan facility for business requirements
|
|
18-Feb-2025
|
20-Feb-2025
|
Inter alia, to consider and approve:- 1. allotment of equity shares pursuant to exercise of option attached to 250 Optionally Convertible Debentures ("OCDs") having a face value of ?10,00,000/- each by India Credit Opportunities Fund II, option holder. 2. Any other businesses with the permission of the Chairperson
|
|
30-Jan-2025
|
07-Feb-2025
|
Quarterly Results
|